Abstract
Intra-vascular lymphoma is usually reported as a rare and fatal disorder. We describe here the first case of an intra-vascular lymphoma revealed by a nephrotic syndrome for which a durable remission has been obtained by 8 cycles of bi-mensual CHOP and Rituximab therapy. In this report, 18 fluorodesoxyglucose tomoscintigraphy is discussed as a tool for intra-vascular lymphoma extension and follow-up.
MeSH terms
-
Aged
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cyclophosphamide / therapeutic use*
-
Doxorubicin / therapeutic use*
-
Female
-
Humans
-
Lymphoma, B-Cell / drug therapy*
-
Lymphoma, B-Cell / pathology
-
Lymphoma, Large B-Cell, Diffuse / drug therapy*
-
Lymphoma, Large B-Cell, Diffuse / pathology
-
Nephrotic Syndrome / pathology*
-
Prednisone / therapeutic use*
-
Remission Induction
-
Rituximab
-
Tomography, Emission-Computed, Single-Photon
-
Vascular Neoplasms / drug therapy*
-
Vascular Neoplasms / pathology
-
Vincristine / therapeutic use*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone